Research Developments and Therapy Advancements in B-Cell Malignancies

Submitted by admin5 on Mon, 11/20/2017 - 16:14

B-cell malignancies are among the most deadly and difficult-to-treat blood disorders. Our understanding of treatment options, prognostic indicators, and value in B-cell malignancies is constantly evolving. Within the past 6 months, there have been numerous breakthroughs in B-cell malignancy therapies, biomarkers, prognoses, and mutational understandings. Review the late breakthroughs in this field since the early summer.